VersaBank (VBNK)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 32.69 |
|---|---|
| 52-week range | 15.80 – 34.00 |
| Return, 1 month / 3 months | +1.2% / +17.3% |
| Return, 1 year / 3 years | +97.2% / +221.1% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 39.5% |
| Worst drawdown (1 year) | -21.0% |
| Average daily value traded | 1.08M CAD |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
VersaBank is a Canadian chartered bank based in London, Ontario, that operates without a traditional branch network. It takes deposits and provides commercial lending, including financing arranged through partners and receivable purchase programmes for businesses. The bank also offers digital banking and treasury services to other financial institutions and deposit brokers. Its customers are mainly businesses and institutional clients across Canada, served through electronic channels rather than physical branches.
The shares are listed on the Toronto Exchange in Canada under the code VBNK, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VersaBank (VBNK) trades on the Toronto Exchange in Canada. It last closed at CAD 32.69 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 116 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 97.2% and over the last three months it rose 17.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 27.1% | ||
| From 52-week high | -1.7% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 17.3% | ||
| 6-month return | 34.0% | ||
| 12-month return, skipping the last month | 94.8% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.0% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.08M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 18 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | +1.2% |
| 3 months | +17.3% |
| 6 months | +34.0% |
| 1 year | +97.2% |
| 3 years | +221.1% |
| 5 years | +127.8% |
Signals
| 50-day / 200-day average | 30.29 / 25.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Oct 2026 | CAD 0.0250 |
| 10 Jul 2026 | CAD 0.0250 |
| 10 Apr 2026 | CAD 0.0250 |
| 9 Jan 2026 | CAD 0.0250 |
| 10 Oct 2025 | CAD 0.0250 |
| 4 Jul 2025 | CAD 0.0250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.